-
Celator Surges 70% After Acquisition Announcement By Jazz Pharmaceuticals
Tuesday, May 31, 2016 - 8:28am | 364Read More...Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) surged higher by more than 70 percent early Tuesday morning after the company has agreed to be acquired by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for approximately $1.5 billion, or $30.25 per share. Celator's stock closed for trading at...
-
Allergan Announces Acquisition Of Topokine Therapeutics, Highlights Fat Reduction Development Program
Friday, April 22, 2016 - 9:56am | 362Read More...Allergan plc (NYSE: AGN) announced on Thursday it has entered into an agreement to acquire Topokine Therapeutics, a privately held, clinical-stage biotechnology that focuses on the development of topical medicines for fat reduction. As part of the agreement, Allergan made an up-font payment of $85...
-
Medivation Ticks Up 3%, AstraZeneca Said To Be Also Interested In Acquisition
Monday, April 18, 2016 - 8:31am | 203Read More...Shares of Medivation Inc (NASDAQ: MDVN) were trading higher by more than 3 percent early Monday following reports the company is being eyed as an acquisition target by more than one potential buyer. Medivation has already received interest from Sanofi SA (ADR) (NYSE: SNY) and analysts suggested...
-
Allergan Gains 1.50% Following Q4 Beat, Company Updates On M&A Activity
Monday, February 22, 2016 - 9:51am | 327Read More...Shares of Allergan plc Ordinary Shares (NYSE: AGN) were trading higher by more than 1.50 percent on Monday after the company reported its fourth quarter results. Allergan said that it earned $3.41 per share in the fourth quarter on revenue of $4.2 billion. Wall Street analysts were expecting the...
-
Intercept Pharmaceuticals Soars 30%; Reuters Reported Company Exploring A Potential Sale
Friday, February 12, 2016 - 2:43pm | 156Read More...Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) soared higher by more than 30 percent after Reuters reported the company is exploring a potential sale of itself. Reuters, citing "people familiar with the matter," stated that Intercept has received interest from other companies...
-
Perrigo Spikes After Rumors It's Withdrawing From Leerink Conference
Friday, January 22, 2016 - 1:29pm | 156Read More...Shares of Perrigo Company plc Ordinary Shares (NYSE: PRGO) spiked higher on Friday after rumors circulated that the company is withdrawing its attendance at a Leerink conference. There are several reasons why a company would withdraw its attendance at an analyst hosted or industry-wide...
-
XenoPort Continues Higher Amid Takeover Rumors
Friday, January 22, 2016 - 10:01am | 108Read More...Shares of XenoPort, Inc. (NASDAQ: XNPT) were trading higher by nearly 6 percent at $5.07 early Friday morning. Reuters reported late Thursday afternoon that the bio-pharmaceutical company is in the early stages of exploring a potential sale of itself. Citing "people familiar with the...
-
Report: AstraZeneca Eyes Acquisition Of Relypsa For $46 Per Share
Thursday, December 24, 2015 - 8:53am | 122Read More...Shares of Relypsa Inc (NASDAQ: RLYP) were trading higher by more than 2 percent at $28.60 early Thursday morning after the Daily Mail reported the company may be a potential acquisition target. The Daily Mail reported that "rumors from across the Pond" suggest that AstraZeneca plc (...
-
How Allergan Could Be Pfizer's Rocket Ship
Thursday, October 29, 2015 - 12:19pm | 583Read More...Pfizer Inc. (NYSE: PFE) confirmed media reports that the company is in talks with Allergan PLC (NYSE: AGN) over a potential business combination transaction. Pfizer said it is in "preliminary friendly discussions" with Allergan, but offered no assurances that the conversations will...
-
5 Specialty Pharma Stocks Nomura Is Picking To Weather The Storm
Tuesday, September 29, 2015 - 3:27pm | 494Read More...Shibani Malhotra of Nomura is expecting the specialty pharmaceutical and generics "merger frenzy" will continue into 2016. Malhotra argued that companies with access to capital are now "more likely" to pursue deals, be it either friendly or hostile. However, Malhotra cautioned that investor...
